RankingsLogo

Catalent Inc.

Catalent Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.

Catalent, Inc., provides CDMO services, delivery technologies and manufacturing solutions to develop pharmaceuticals, biologics and consumer health products.

Ticker: CTLT

Humankind Value: $39.9 B

Revenue: $3.9 B

Market Cap: $10.2 B

Badge100_2024
Positive and negative impacts of companies graphic.

(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)

Catalent, Inc. creates positive Humankind Value on the whole, with much of its positive value coming from Healthcare R&D ($24.3 B), Pharmaceuticals ($12.0 B), and Economic Value ($2.7 B). The value associated with Healthcare R&D and Pharmaceuticals contains our estimation of 700,000 additional years lived by people worldwide. This firm can increase its Humankind Value by addressing Biofuel Production (-$316.0 M) and Greenhouse Gases (-$268.5 M). Healthcare R&D, Pharmaceuticals, Economic Value, Biofuel Production, and Greenhouse Gases are mostly or entirely a result of supply-chain relationships. While this company has a positive Humankind Value when studied in isolation, consideration of supply chain interactions pushes its Humankind Value higher.

How the Humankind Value Methodology Drives the Rankings

We take a quantitative, data-driven approach to estimating the economic impact that companies have on investors, customers, employees, and society at large, rolling social responsibility into a single dollar value that we use to represent what a company is contributing to humanity. As far as we can tell, we're the first ones doing it this way.

LEARN MORE ABOUT OUR RESEARCH
How Methodology Drives the Rankings